![Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial - eClinicalMedicine Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0a12838f-795c-4222-b73d-13c62ab2e117/gr1.jpg)
Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial - eClinicalMedicine
![Frontiers | Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients Frontiers | Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients](https://www.frontiersin.org/files/Articles/645130/fphar-12-645130-HTML-r3/image_m/fphar-12-645130-g001.jpg)
Frontiers | Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients
![Diagnostics | Free Full-Text | Diagnostic Modalities in Critical Care: Point-of-Care Approach | HTML Diagnostics | Free Full-Text | Diagnostic Modalities in Critical Care: Point-of-Care Approach | HTML](https://www.mdpi.com/diagnostics/diagnostics-11-02202/article_deploy/html/images/diagnostics-11-02202-g001.png)
Diagnostics | Free Full-Text | Diagnostic Modalities in Critical Care: Point-of-Care Approach | HTML
![Frontiers | SDF4 Is a Prognostic Factor for 28-Days Mortality in Patients With Sepsis via Negatively Regulating ER Stress Frontiers | SDF4 Is a Prognostic Factor for 28-Days Mortality in Patients With Sepsis via Negatively Regulating ER Stress](https://www.frontiersin.org/files/Articles/659193/fimmu-12-659193-HTML/image_m/fimmu-12-659193-g001.jpg)